INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS

DEWITTE T SUCIU S BOOGAERTS M LABAR B ARCHIMBAUD E AUL C SELLESLAG D FERRANT A WEIJERMANS P MANDELLI F AMADORI S MUUS P DEMUYNCK H DARDENNE M WILLEMZE R GRATWOHL A APPERLEY J

T. Dewitte et al., INTENSIVE ANTILEUKEMIC THERAPY INCLUDING STEM-CELL TRANSPLANTATION (SCT) FOR HIGH-RISK MDS AND AML FOLLOWING MDS (SAML) IN PATIENTS LESS-THAN-60 YEARS - A JOINT STUDY OF THE EORTC AND THE EBMT LEUKEMIA GROUPS, Experimental hematology, 24(9), 1996, pp. 678-678

NO

Medicine, Research & Experimental",Hematology

Experimental hematology → ACNP

0301472X

24

9

1996

678 - 678

ISI

0301-472X(1996)24:9<678:IATIST>2.0.ZU;2-A